FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061730571> ?p ?o ?g. }

• W2061730571 endingPage "34" @default.
• W2061730571 startingPage "34" @default.
• W2061730571 abstract "We have previously reported that ipodate (1g, q.d.) compares favorably to PTU (200 mg, t.i.d.) in the treatment of Graves' hyperthyroid patients in 3-wk therapy (J Clin Endocrinol Metab 54:630, 1982). This report presents the results of five newly diagnosed Graves' hyperthyroid patients who were given 500 mg ipodate daily for 23 to 35 wks. Mean baseline serum T3, T4 and rT3 were 780 ng/dl, 25.4 ug/d1 and 118 ng/dl, respectively. One day after the first dose of ipodate, serum T3 decreased by 62% (P<0.005) and stayed within the normal range throughout the treatment. The serum T4 concentration decreased by 20% (P=0.09) at 24 h, 35% at 3 d(P<0.02) and 54% (P<0.005) at 21 d. Subsequently serum T4 was 41–65% lower than baseline throughout the study; it was within the normal range in four patients from 10 wks of treatment on. Serum rT3 increased at 24 h following the first dose of ipodate (118% above baseline, P<0.05 and remained elevated (97–109%) for 10 wks and then gradually decreased to baseline level. A significant decrease of resting pulse rate and marked gain in body weight (11±2.4 1b) were observed in all patients. Following the discontinuation of ipodate, thyroid radioiodine uptake in four patients was not different from baseline value: baseline, 74 ±6%; 7 d 66±8%; 14 d 71±7%; 28 d 69±7%. The fifth patient's RAI uptake Fell to 12–16% (vs. baseline value of 48%) from 7–28 d after the end of a 26-wk course of ipodate. In conclusion: (1) long term use (for 23–35 wks) of ipodate for the treatment of Graves' hyperthyroidism is clinically feasible; and (2) RAI uptake returns to baseline level as early as 7 d following the discontinuation of ipodate." @default.
• W2061730571 created "2016-06-24" @default.
• W2061730571 creator A5004342307 @default.
• W2061730571 creator A5026327210 @default.
• W2061730571 creator A5042833954 @default.
• W2061730571 creator A5047597573 @default.
• W2061730571 creator A5067402052 @default.
• W2061730571 creator A5068304636 @default.
• W2061730571 creator A5071433569 @default.
• W2061730571 creator A5085825455 @default.
• W2061730571 date "1984-09-01" @default.
• W2061730571 modified "2023-10-18" @default.
• W2061730571 title "LONG-TERM TREATMENT OF GRAVES' HYPERTHYROIDISM WITH IPODATE" @default.
• W2061730571 doi "https://doi.org/10.1097/00003072-198409001-00018" @default.
• W2061730571 hasPublicationYear "1984" @default.
• W2061730571 type Work @default.
• W2061730571 sameAs 2061730571 @default.
• W2061730571 citedByCount "0" @default.
• W2061730571 crossrefType "journal-article" @default.
• W2061730571 hasAuthorship W2061730571A5004342307 @default.
• W2061730571 hasAuthorship W2061730571A5026327210 @default.
• W2061730571 hasAuthorship W2061730571A5042833954 @default.
• W2061730571 hasAuthorship W2061730571A5047597573 @default.
• W2061730571 hasAuthorship W2061730571A5067402052 @default.
• W2061730571 hasAuthorship W2061730571A5068304636 @default.
• W2061730571 hasAuthorship W2061730571A5071433569 @default.
• W2061730571 hasAuthorship W2061730571A5085825455 @default.
• W2061730571 hasConcept C126322002 @default.
• W2061730571 hasConcept C134018914 @default.
• W2061730571 hasConcept C2778288131 @default.
• W2061730571 hasConcept C2778715236 @default.
• W2061730571 hasConcept C2780486670 @default.
• W2061730571 hasConcept C526584372 @default.
• W2061730571 hasConcept C71924100 @default.
• W2061730571 hasConcept C90924648 @default.
• W2061730571 hasConceptScore W2061730571C126322002 @default.
• W2061730571 hasConceptScore W2061730571C134018914 @default.
• W2061730571 hasConceptScore W2061730571C2778288131 @default.
• W2061730571 hasConceptScore W2061730571C2778715236 @default.
• W2061730571 hasConceptScore W2061730571C2780486670 @default.
• W2061730571 hasConceptScore W2061730571C526584372 @default.
• W2061730571 hasConceptScore W2061730571C71924100 @default.
• W2061730571 hasConceptScore W2061730571C90924648 @default.
• W2061730571 hasIssue "Supplement 9" @default.
• W2061730571 hasLocation W20617305711 @default.
• W2061730571 hasOpenAccess W2061730571 @default.
• W2061730571 hasPrimaryLocation W20617305711 @default.
• W2061730571 hasRelatedWork W1966618050 @default.
• W2061730571 hasRelatedWork W1970122186 @default.
• W2061730571 hasRelatedWork W2008483405 @default.
• W2061730571 hasRelatedWork W2022282000 @default.
• W2061730571 hasRelatedWork W2046841966 @default.
• W2061730571 hasRelatedWork W2066485846 @default.
• W2061730571 hasRelatedWork W2070295037 @default.
• W2061730571 hasRelatedWork W2070480234 @default.
• W2061730571 hasRelatedWork W2156615339 @default.
• W2061730571 hasRelatedWork W2413042786 @default.
• W2061730571 hasVolume "9" @default.
• W2061730571 isParatext "false" @default.
• W2061730571 isRetracted "false" @default.
• W2061730571 magId "2061730571" @default.
• W2061730571 workType "article" @default.